CervoMed (CRVO) Cash from Operations (2010 - 2026)
CervoMed (CRVO) posted Cash from Operations of 8018338.0 for Q1 2026, down 21.94% sequentially from 6575699.0 in Q4 2025, and down 105.9% YoY from 135991145.18 in Q1 2025.
CervoMed (CRVO) Cash from Operations (2010 - 2026) Analysis & Trends
CervoMed has reported Cash from Operations for 17 years, with the latest figure at 8018338.0 in Q1 2026.
- Quarterly Cash from Operations fell 105.9% year-over-year to 8018338.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 27573942.0 (down 45.11% YoY) and the FY2025 annual result came in at 23449963.0, down 41.86% from the prior year.
- Cash from Operations eased to 8018338.0 in Q1 2026 per CRVO's latest filing, from 6575699.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 6856778.0 in Q3 2022 and troughed at 8050918.0 in Q4 2024.
- A 5-year average of 3413043.18 and a median of 3894359.0 in 2025 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2023: Cash from Operations soared 330.67% in 2022, then plunged 266.55% in 2023.
- Over 5 years, Cash from Operations stood at 692530.0 in 2022, then slumped by 266.55% to 2538454.0 in 2023, then sank by 217.16% to 8050918.0 in 2024, then gained by 18.32% to 6575699.0 in 2025, then slipped by 21.94% to 8018338.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 8018338.0, 6575699.0, and 6465210.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - | -6.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.92 Mn |
| Jun 30, 2026 | -6.92 Mn |
| Mar 31, 2026 | -8.02 Mn |
| Mar 31, 2026 | -8.02 Mn |
| Dec 31, 2025 | -6.58 Mn |
| Dec 31, 2025 | -6.58 Mn |
| Sep 30, 2025 | -6.47 Mn |
| Sep 30, 2025 | -6.47 Mn |
| Jun 30, 2025 | -6.51 Mn |
| Jun 30, 2025 | -6.51 Mn |
| Mar 31, 2025 | -3.89 Mn |
| Mar 31, 2025 | -3.89 Mn |
| Dec 31, 2024 | -8.05 Mn |
| Dec 31, 2024 | -8.05 Mn |
| Sep 30, 2024 | -4.85 Mn |
| Sep 30, 2024 | -4.85 Mn |
| Jun 30, 2024 | -2.20 Mn |
| Jun 30, 2024 | -2.20 Mn |
| Mar 31, 2024 | -1.42 Mn |
| Mar 31, 2024 | -1.42 Mn |